Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 11/20 | 0.38 |
| ▸ | TNF | P01375 | 5/20 | 0.31 |
| ▸ | LITAF | Q99732 | 5/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL870531 | 1.00 | PDE4B (0.38) | PDE4BTNFLITAFPDE4DSSTR2 | |
| SCHEMBL872002 | 0.93 | METAP2 (0.36) | PDE4BTNFLITAFPDE4DCYP3A4 | |
| SCHEMBL872001 | 0.93 | METAP2 (0.36) | PDE4BTNFLITAFPDE4DCYP3A4 | |
| SCHEMBL872270 | 0.89 | PDE4B (0.42) | PDE4BPDE4DCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL872271 | 0.89 | PDE4B (0.42) | PDE4BPDE4DCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL871084 | 0.88 | TNF (0.32) | PDE4BTNFLITAFPDE4DPIK3CA | |
| SCHEMBL871083 | 0.88 | TNF (0.32) | PDE4BTNFLITAFPDE4DPIK3CA | |
| SCHEMBL872979 | 0.88 | PDE4B (0.35) | PDE4BTNFLITAFPDE4DKCNH2 | |
| SCHEMBL872980 | 0.88 | PDE4B (0.35) | PDE4BTNFLITAFPDE4DKCNH2 | |
| SCHEMBL870772 | 0.87 | PDE4B (0.40) | PDE4BTNFLITAFSSTR2PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077801-A1 | Chemical Compounds 637 | ALCON RESEARCH, LTD. | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077801-A1 | Chemical Compounds 637 | PDE4A, PDE4B, PDE3B | PDE4B 2/4885TNF 1585/4885LITAF 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.